Literature DB >> 28295919

Interplay between siderophores and colibactin genotoxin in Escherichia coli.

Patricia Martin1,2, Sophie Tronnet1, Christophe Garcie1,2, Eric Oswald1,2.   

Abstract

Highly pathogenic Escherichia coli strains that belong to the phylogenetic group B2 have developed a greater ability to acquire iron (heme receptor and numerous siderophores), to produce the genotoxin colibactin and to synthesize antimicrobial siderophore-microcins. There is an increased prevalence of these E. coli strains over the last 30 years in the intestinal microbiota in industrialized countries. Integrating the regulation of fitness/virulence factors, such as siderophores, colibactin and siderophore-microcins into networks that respond to specific environmental signals, such as the local iron concentration, could result in an accurate production of specific fitness/virulence factors, so that the E. coli can adapt to the competitive environment that is the gut and/or the blood. Iron deficiency is common in infancy, even in industrialized countries. Usual strategies for anemia correction are iron supplementation and iron fortification of foods. The long-term consequences and risks associated with high iron supply in the light of this iron-dependent network described in this review could explain at least in part the increased prevalence of E. coli B2 in the gut of people in industrialized countries.
© 2017 IUBMB Life, 69(6):435-441, 2017. © 2017 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  E. coli; commensalism; iron; pathogenesis

Mesh:

Substances:

Year:  2017        PMID: 28295919     DOI: 10.1002/iub.1612

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  12 in total

1.  Hepcidin Protects against Lethal Escherichia coli Sepsis in Mice Inoculated with Isolates from Septic Patients.

Authors:  Deborah Stefanova; Antoan Raychev; Jaime Deville; Romney Humphries; Shelley Campeau; Piotr Ruchala; Elizabeta Nemeth; Tomas Ganz; Yonca Bulut
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

Review 2.  Signaling Natural Products from Human Pathogenic Bacteria.

Authors:  Zhijuan Hu; Wenjun Zhang
Journal:  ACS Infect Dis       Date:  2019-10-30       Impact factor: 5.084

Review 3.  Molecular Basis of Gut Microbiome-Associated Colorectal Cancer: A Synthetic Perspective.

Authors:  Alan R Healy; Seth B Herzon
Journal:  J Am Chem Soc       Date:  2017-10-12       Impact factor: 15.419

Review 4.  Escherichia coli small molecule metabolism at the host-microorganism interface.

Authors:  Alexandra Gatsios; Chung Sub Kim; Jason M Crawford
Journal:  Nat Chem Biol       Date:  2021-09-22       Impact factor: 15.040

5.  Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy.

Authors:  Valerio Iebba; Francesca Guerrieri; Vincenza Di Gregorio; Massimo Levrero; Antonella Gagliardi; Floriana Santangelo; Anatoly P Sobolev; Simone Circi; Valerio Giannelli; Luisa Mannina; Serena Schippa; Manuela Merli
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

6.  Molecular Genetic and Functional Analysis of pks-Harboring, Extra-Intestinal Pathogenic Escherichia coli From India.

Authors:  Arya Suresh; Amit Ranjan; Savita Jadhav; Arif Hussain; Sabiha Shaik; Munirul Alam; Ramani Baddam; Lothar H Wieler; Niyaz Ahmed
Journal:  Front Microbiol       Date:  2018-11-15       Impact factor: 5.640

7.  Characterization of Escherichia coli harboring colibactin genes (clb) isolated from beef production and processing systems.

Authors:  Manita Guragain; John W Schmidt; Norasak Kalchayanand; Aaron M Dickey; Joseph M Bosilevac
Journal:  Sci Rep       Date:  2022-03-29       Impact factor: 4.996

8.  Genomic Insights into Drug Resistance and Virulence Platforms, CRISPR-Cas Systems and Phylogeny of Commensal E. coli from Wildlife.

Authors:  Carla Andrea Alonso; María de Toro; Fernando de la Cruz; Carmen Torres
Journal:  Microorganisms       Date:  2021-05-05

9.  Mcc1229, an Stx2a-Amplifying Microcin, Is Produced In Vivo and Requires CirA for Activity.

Authors:  Erin M Nawrocki; Laura E Hutchins; Kathryn A Eaton; Edward G Dudley
Journal:  Infect Immun       Date:  2021-12-06       Impact factor: 3.441

10.  Two Polyketides Intertwined in Complex Regulation: Posttranscriptional CsrA-Mediated Control of Colibactin and Yersiniabactin Synthesis in Escherichia coli.

Authors:  Nadine Rehm; Alexander Wallenstein; Marla Keizers; Stefan Homburg; Giuseppe Magistro; Camille V Chagneau; Hanna Klimek; Olga Revelles; Emmanuelle Helloin; Johannes Putze; Jean-Philippe Nougayrède; Sören Schubert; Eric Oswald; Ulrich Dobrindt
Journal:  mBio       Date:  2022-02-01       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.